Document Classification

Section Type: METHODS

Text: Patients were randomly assigned to receive FOLFIRI : irinotecan (180 mg/m (2) i. v. on days 1, 15 and 22) ; FA (200 mg/m (2) i. v. on days 1, 2, 15, 16, 29 and 30) ; 5-FU (400 mg/m (2) i. v. bolus, then 22-h, 600 mg/m (2) infusion) or CAPIRI : irinotecan (250 mg/m (2) i. v. infusion on days 1 and 22) ; capecitabine p. o. (1000 mg/m (2) b. i. d. on days 1-15 and 22-36).